| Copper | Approved Investigational | MAP6D1 | 79929 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MAP6D1 mRNA | 3q27.1 | |
| Copper | Approved Investigational | MAPK12 | 6300 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MAPK12 mRNA | 22q13.33 | |
| Copper | Approved Investigational | MAPK15 | 225689 |
upregulated | [Organoselenium Compounds binds to Copper] which results in increased expression of MAPK15 mRNA | 8q24.3 | |
| Copper | Approved Investigational | MAPRE2 | 10982 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of MAPRE2 mRNA | 18q12.1-q12.2 | |
| Copper | Approved Investigational | MARC1 | 64757 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MARC1 mRNA | 1q41 | |
| Copper | Approved Investigational | MARC2 | 54996 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MARC2 mRNA | 1q41 | |
| Copper | Approved Investigational | MARCKS | 4082 |
downregulated | Copper results in decreased expression of MARCKS mRNA | 6q21 | |
| Copper | Approved Investigational | MARVELD1 | 83742 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MARVELD1 mRNA | 10q24.2 | |
| Copper | Approved Investigational | MATN2 | 4147 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA | 8q22.1-q22.2 | |
| Copper | Approved Investigational | MAX | 4149 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of MAX mRNA | 14q23.3 | |
| Copper | Approved Investigational | MBD1 | 4152 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of MBD1 mRNA | 18q21.1 | |
| Copper | Approved Investigational | MBD3 | 53615 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MBD3 mRNA | 19p13 | |
| Copper | Approved Investigational | MBNL1 | 4154 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of MBNL1 mRNA | 3q25.1-q25.2 | |
| Copper | Approved Investigational | MBNL3 | 55796 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MBNL3 mRNA | Xq26.2 | |
| Copper | Approved Investigational | MCAM | 4162 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCAM mRNA | 11q23.3 | |
| Copper | Approved Investigational | MCCC2 | 64087 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCCC2 mRNA | 5q13.2 | |
| Copper | Approved Investigational | MCM10 | 55388 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM10 mRNA | 10p13 | |
| Copper | Approved Investigational | MCM2 | 4171 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM2 mRNA | 3q21.3 | |
| Copper | Approved Investigational | MCM3 | 4172 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM3 mRNA | 6p12.2 | |
| Copper | Approved Investigational | MCM4 | 4173 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM4 mRNA | 8q11.21 | |
| Copper | Approved Investigational | MCM5 | 4174 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM5 mRNA | 22q12.3 | |
| Copper | Approved Investigational | MCM6 | 4175 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM6 mRNA | 2q21.3 | |
| Copper | Approved Investigational | MCM7 | 4176 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCM7 mRNA | 7q22.1 | |
| Copper | Approved Investigational | MCMBP | 79892 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCMBP mRNA | 10q26.11 | |
| Copper | Approved Investigational | MCTP2 | 55784 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of MCTP2 mRNA | 15q26.2 | |